Clinical trial / 2006
One-month soy isoflavone supplementation achieved high plasma isoflavone concentrations but did not induce equol production in non-producers.
Twelve postmenopausal women ingested 100 mg isoflavones/day (aglycone equivalents in cereal bars and yogurts) for 1 month to assess bioavailability and equol production. Similar plasma kinetic curves and urinary excretion were observed for genistein and daidzein between days 1 and 30. In equol producers, maximum plasma equol increased from 0.31+/-0.27 to 0.99+/-0.51 micromol/l (P=0.046), but the seven baseline non-producers did not gain the ability to produce equol after 1 month.
- Study type
- Intervention trial (pre-post evaluation)
- Who was studied
- 12 Caucasian postmenopausal women
- What was measured
- Plasma concentrations and 36-h urinary excretion of isoflavone metabolites and equol production capacity
THE PAPER
One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N, Mathey J, Morand C, Brandolini M, Davicco MJ, Guy L, Rémésy C, Coxam V, Manach C. Eur J Clin Nutr, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.